Specifically, deleterious variants of TNFRSF13B (TACI) are present in 1% of healthy individuals in public databases but in 10% of those with CVID, suggesting that this genetic background contributes to CVID but cannot drive the CVID phenotype alone (93). This evidence concerns the gene TNFRSF13B and common variable immunodeficiency.